Business, energy, technology, markets and global industry news from Business News Today

VISUfarma

Pharma & Biotech

Lupin’s VISUfarma gets exclusive European YUVEZZI rights as presbyopia eye drops become a competitive category

Lupin’s VISUfarma will handle YUVEZZI regulation and commercialization across the EU, UK and selected European markets, while Tenpoint receives an investment, milestones and tiered royalties.

Read More
Pharma & Biotech

Lupin closes VISUfarma deal, but can branded ophthalmology drive the next phase of growth?

Lupin has completed its VISUfarma acquisition. Read what the deal changes for European ophthalmology, specialty pharma growth, and execution risk.

Read More